indazoles has been researched along with Parkinsonian Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ago, Y; Hiramatsu, N; Matsuda, T; Ota, Y; Takahashi, T; Takuma, K; Tanaka, T | 1 |
| Chalimoniuk, M; Langfort, J; Lukacova, N; Marsala, J | 1 |
| Mohanakumar, KP; Saravanan, KS; Thomas, B | 1 |
| Araki, T; Kato, H; Takagi, S; Watanabe, Y; Yokoyama, H | 1 |
4 other study(ies) available for indazoles and Parkinsonian Disorders
| Article | Year |
|---|---|
Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats.
Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Dopamine and cAMP-Regulated Phosphoprotein 32; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Indazoles; Levodopa; Male; Neostriatum; Nerve Tissue Proteins; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type I; Parkinsonian Disorders; Protein Subunits; Proto-Oncogene Proteins c-fos; Random Allocation; Rats; Rats, Wistar; Receptors, AMPA; Signal Transduction | 2012 |
Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Cell Count; Cyclic GMP; Disease Models, Animal; Drug Administration Schedule; Gene Expression Regulation; Guanylate Cyclase; Immunohistochemistry; Indazoles; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Parkinsonian Disorders; Time Factors; Tyrosine 3-Monooxygenase | 2006 |
In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole.
Topics: Animals; Antioxidants; Basal Ganglia; Brain; Catalase; Cytoprotection; Enzyme Inhibitors; Glutathione; Indazoles; Mice; Mice, Inbred BALB C; Mitochondria; Monoamine Oxidase; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type I; Oxidative Stress; Oxidoreductases; Parkinsonian Disorders; Substantia Nigra; Superoxide Dismutase | 2008 |
Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Cytoprotection; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activators; Enzyme Inhibitors; Free Radical Scavengers; Glial Fibrillary Acidic Protein; Gliosis; Homovanillic Acid; Indazoles; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Parkinsonian Disorders; Reactive Nitrogen Species; Reactive Oxygen Species; Tyrosine 3-Monooxygenase | 2008 |